The OPT Congress brings together leading scientists and clinicians involved in developing RNA therapeutics together to discuss the latest advances in oligonucleotide and mRNA drugs. Visit our booth to discuss our innovative approaches for characterizing and validating RNA therapeutics including:

• miR-eCLIP +siRNA for directly measuring siRNA off-target activity
• eRibo Pro for measuring both expression and translation
• eSHAPE for obtaining the secondary structure of mRNA therapeutics and RNA targets

Interested in learning how Eclipsebio can help you achieve your RNA therapeutic goals? Contact us today to start a project.